Last kr53.00 SEK
Change Today -1.00 / -1.85%
Volume 1.3K
BOUL On Other Exchanges
Symbol
Exchange
Stockholm
As of 11:29 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

boule diagnostics internatio (BOUL) Snapshot

Open
kr52.00
Previous Close
kr54.00
Day High
kr53.00
Day Low
kr51.75
52 Week High
11/5/14 - kr59.25
52 Week Low
02/10/14 - kr39.10
Market Cap
249.5M
Average Volume 10 Days
1.7K
EPS TTM
kr-14.90
Shares Outstanding
4.7M
EX-Date
05/14/14
P/E TM
--
Dividend
kr0.50
Dividend Yield
0.94%
Current Stock Chart for BOULE DIAGNOSTICS INTERNATIO (BOUL)

Related News

No related news articles were found.

boule diagnostics internatio (BOUL) Related Businessweek News

No Related Businessweek News Found

boule diagnostics internatio (BOUL) Details

Boule Diagnostics AB, a diagnostics company, develops, manufactures, and markets complete blood count systems for the healthcare sector in Sweden and internationally. The company offers hematology systems, including reagents, calibrators, controls, analyzers, and accessories for the human and veterinary markets under the exigo, Medonic, Swelab, and Quintus brand names. It primarily serves small and midsize hospitals, clinics, and laboratories in out-patient care. The company was founded in 1956 and is headquartered in Stockholm, Sweden.

Founded in 1956

boule diagnostics internatio (BOUL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

boule diagnostics internatio (BOUL) Key Developments

Boule Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2014

Boule Diagnostics AB reported earnings results for the first quarter ended March 31, 2014. Net sales totaled SEK 73.3 million, up 15.6% from SEK 63.4 million reported in the same period last year. Changes in the USD and EUR exchange rates had a positive impact of SEK 0.6 million on net sales. Cash flow from operating activities totaled SEK 9.1 million against SEK 1.4 million reported last year. Operating profit was SEK 6.3 million against SEK 0.5 million reported last year. Net profit was SEK 4.3 million or SEK 0.91 per share against a loss of SEK 1.7 million or SEK 0.36 per share reported last year.

Boule Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 2013

Boule Diagnostics AB reported earnings results for the third quarter and nine months ended September 2013. For the quarter, the company reported net sales totaled SEK 69.9 million against SEK 63.8 million, up 9.6%. Changes in the USD and EUR exchange rates had a negative impact of SEK 0.2 million on net sales. The operating result was a loss of SEK 91.7 million against a profit of SEK 1.5 million a year ago. Excluding impairment charges of SEK 95.5 million, the operating result was profit of SEK 3.8 million against a profit of SEK 1.5 million a year ago. The net result was a loss of SEK 72.4 million against a profit of SEK 0.9 million a year ago. Net profit before impairment charges was SEK 4.5 million. The result per share was a loss of SEK 15.38 against a profit of SEK 0.19 year ago. Earnings per share before impairment charges amounted to SEK 0.96 against SEK 0.19 million a year ago. For the nine months, the company reported net sales totaled SEK 204.6 million against SEK 199.0 million, up 2.8% Changes in the USD and EUR exchange rates had a negative impact of SEK 3.3 million on net sales. The operating result was a loss of SEK 85.6 million against a profit of SEK 14.3 million a year ago. Excluding impairment charges of SEK 95.5 million, the operating result was profit of SEK 9.9 million against a profit of SEK 14.3 million a year ago. The net result was a loss of SEK 68.2 million. Net profit before impairment charges was SEK 8.7 million against a profit of SEK 7.7 million a year ago. The result per share was a loss of SEK 14.49 against a profit of SEK 1.63 a year ago. Earnings per share before impairment charges amounted to SEK 1.85 against SEK 1.6 a year ago.

Boule Diagnostics AB to Report Fiscal Year 2013 Results on Feb 07, 2014

Boule Diagnostics AB announced that they will report fiscal year 2013 results on Feb 07, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BOUL:SS kr53.00 SEK -1.00

BOUL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BOUL.
View Industry Companies
 

Industry Analysis

BOUL

Industry Average

Valuation BOUL Industry Range
Price/Earnings 17.1x
Price/Sales 0.8x
Price/Book 1.6x
Price/Cash Flow 17.1x
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOULE DIAGNOSTICS INTERNATIO, please visit www.boule.se. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.